Cutler Group’s Kite Pharma, Inc. KITE Stock Holding History

Cutler Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-168,700	Closed	-$6.45M	–	6647
2017 Q3	$6.45M	Buy	168,700 +67,600	+67%	+$9.42M	0.24%	55
2017 Q2	$2.15M	Sell	101,100 -800	-0.8%	-$65.3K	0.08%	206
2017 Q1	$1.43M	Buy	101,900 +53,400	+110%	+$3.3M	0.06%	271
2016 Q4	$91K	Sell	48,500 -80,100	-62%	-$3.93M	﹤0.01%	1992
2016 Q3	$221K	Buy	128,600 +92,700	+258%	+$5.16M	0.01%	1128
2016 Q2	$77K	Sell	35,900 -27,600	-43%	-$1.36M	﹤0.01%	1943
2016 Q1	$143K	Sell	63,500 -5,500	-8%	-$266K	0.01%	1285
2015 Q4	$152K	Buy	+69,000	New	+$4.86M	0.01%	1401

Cutler Group's KITE Position: Q4 2017 in Review

Cutler Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 4,684 shares — an estimated $842K sold.

Cutler Group first reported a position in KITE in Q4 2015 and held it in 8 quarters. The position peaked at $969K in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Cutler Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Cutler Group sold 4,684 Kite Pharma, Inc. shares in Q4 2017, an estimated $842K.
Cutler Group first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 8 quarters.
Cutler Group's Kite Pharma, Inc. position peaked at $969K in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.